Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rxolve Soothe is a preservative-free, multi-dose topical ophthalmic formulation developed by Rxilient Health for the management of Dry Eye Syndrome and ocular surface recovery. The formulation combines 0.15% high molecular weight hyaluronic acid, which provides long-lasting lubrication and hydration by mimicking natural tear film properties, with Vitamin B5 (pantothenic acid), which supports the metabolic processes required for corneal epithelial repair. It is indicated for mild-to-moderate dry eye symptoms, including redness, irritation, and itchiness, and is specifically recommended for use in pre- and post-ocular surgical care. The product utilizes a specialized bottle design to maintain sterility for up to 12 months without the use of potentially irritating preservatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rxolve Soothe.